ARCHIVES

Herceptin Recommended As Adjuvant For HER2 Positive Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 5 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

White House Gives FDA Authority Over Tobacco Product Sales

August 18, 1995

Medicare’s 21% Pay Cut In Effect Today; Congress Unlikely To Abandon SGR

June 18, 2010

2,000 Breast Cancer Recurrence Biomarker Candidates Discovered

August 31, 2012

NCI Chips In $2 Million For AACR Meeting; Advisors, Senior Staff Not Consulted.

June 20, 2003

Massive New Radiation Research program Costing From $300-$400 Million Over 10 Years Suggested

February 11, 1977

Von Eschenbach Says He Will Step Down as NCI Director; No Acting Director Has Been Named.

March 24, 2006